Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Baylor College of Medicine
- University of North Carolina at Chapel Hill
- University of Maryland, Baltimore
- University of Minnesota
- King's College London
- The Ohio State University
- University of Oxford
- University of Washington
- Duke University
- Rutgers University
- Stanford University
- UNIVERSITY OF HELSINKI
- University of Florida
- University of Nebraska Medical Center
- Human Technopole
- Indiana University
- Institut d'Investigació Biomèdica Sant Pau
- Institut de l'Audition/Institut Pasteur
- Josep Carreras Leukaemia Research Institute (IJC)
- KU LEUVEN
- Massachusetts Institute of Technology
- McGill University
- Nencki Institute of Experimental Biology
- Northeastern University
- Princess Máxima Center for Pediatric Oncology
- RCSI - Royal College of Surgeons in Ireland
- Research Center for Molecular Medicine (CeMM), ÖAW
- St Jude Children's Research Hospital
- The University of Arizona
- The University of Iowa
- Umeå universitet stipendiemodul
- University Hospital Magdeburg
- University of Dundee
- University of Kansas Medical Center
- University of Kentucky
- University of Pittsburgh, Pittsburgh , Pennsylvania, US
- University of Texas at Tyler
- Xi'an Jiaotong - Liverpool University
- Yale University
- 29 more »
- « less
-
Field
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 2 months ago
of which decrease quality and quantity of life. Ironically, recent success in cancer therapies has increased the incidence of clotting complications in patients with cancer. At the same time, we are becoming
-
also has ongoing projects examining the protective role of high-density lipoproteins in these biological pathways and processes, with the goal of developing novel lipoprotein-based therapies
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 2 months ago
looking for a motivated Postdoctoral Research Associates to join our basic and translational research team in the UNC Gene Therapy Center My research is focuses on two general areas: 1) Molecular principles
-
determining astrocyte neurotoxic and neuroprotective phenotype. Basic research concepts studied in the laboratory are being applied to the development of novel gene therapy vectors for the treatment of retinal
-
using Cre-Lox and gene therapy approaches to editing of MP in vivo. The gene therapy approaches are in pre-clinical development as novel therapies for humans with hypertension and heart failure
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 2 months ago
. Chengwen Li in the Gene Therapy Center at the University of North Carolina at Chapel Hill. The general research interest is to develop adeno-associated virus (AAV) vectors to treat various diseases such as
-
the long-term goal of accelerating the development of novel vaccines and therapies. This includes work elucidating how sickle cell trait provides protection against malarial disease. We are particularly
-
to 1) transiently open the blood brain barrier to improve the delivery of gene-therapy (using customized CRISPR-Cas9 agents) and nano-formulated antiretroviral drugs to the brains of rodent models of HIV
-
the laboratory of Dr. Steven Fisher in the Division of Cardiology at the University of Maryland-Baltimore as of April 1, 2019. The federally funded project examines vascular smooth muscle gene expression and
-
the laboratory of Dr. Steven Fisher in the Division of Cardiology at the University of Maryland-Baltimore as of October 1, 2020. The federally funded project examines vascular smooth muscle gene expression and